Search tips
Search criteria 


Logo of jcmPermissionsJournals.ASM.orgJournalJCM ArticleJournal InfoAuthorsReviewers
J Clin Microbiol. 2009 November; 47(11): 3793–3794.
Published online 2009 September 16. doi:  10.1128/JCM.01773-09
PMCID: PMC2772625

Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 Carbapenemase[down-pointing small open triangle]

Tommaso Giani§ and Marco Maria D'Andrea§
Department of Molecular Biology
Section of Microbiology
University of Sienna
Sienna, Italy
Patrizia Pecile
Laboratory of Microbiology
University of Florence Medical School
Careggi University Hospital
Florence, Italy
Luisa Borgianni
Department of Molecular Biology
Section of Microbiology
University of Sienna
Sienna, Italy
Pierluigi Nicoletti
Laboratory of Microbiology
University of Florence Medical School
Careggi University Hospital
Florence, Italy
Francesco Tonelli
Surgery Unit
Department of Clinical Physiopathology
University of Florence Medical School
Careggi University Hospital
Florence, Italy
Alessandro Bartoloni
Department of Critical Medicine and Surgery
Infectious and Tropical Diseases Unit
University of Florence
Florence, Italy

KPC-type carbapenemases are emerging resistance determinants in Klebsiella pneumoniae and other gram-negative pathogens, being an increasingly important mechanism of acquired resistance to carbapenems and other β-lactams (9, 10). KPC producers have recently undergone an important dissemination in the United States, Israel, and Greece and have been sporadically detected elsewhere in Europe, Latin America, and Asia (see references 1, 5, and 9 and references therein). Population analyses of KPC-producing K. pneumoniae isolates by multilocus sequence typing (MLST) have revealed the successful international spread of a sequence type (ST) 258 clone (1, 7, 12).

In this article, we report on the first detection of KPC-producing ST 258 K. pneumoniae in Italy.

(Part of this study was presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 16 to 19 May 2009 [poster P1681]).

K. pneumoniae FIPP-1 was isolated in October 2008 from an inpatient with a complicated intra-abdominal infection at Florence University Hospital. FIPP-1 was resistant to carbapenems (MICs > 32 mg/liter) and other agents, except colistin, gentamicin, and tigecycline (Table (Table1).1). The infection was successfully treated with tigecycline following failure of an empirical carbapenem-based regimen.

Antimicrobial susceptibility profiles of K. pneumoniae FIPP-1 and the E. coli XL-1 transformant XL-1(pFIPP-1) carrying the blaKPC-3 genea

Analysis of β-lactamase genes by PCR and sequencing revealed the presence of blaKPC-3, blaTEM-1, blaOXA-9, and blaSHV-11, while genes encoding other enzymes (CTX-M type, VIM type, and OXA-48) were not detected. MLST analysis (3) assigned FIPP-1 to ST 258. Sequencing of the ompK35 and ompK36 genes (6) showed that both genes were disrupted (by a G insertion at position 122 and by insertion of an IS5-like element, respectively), suggesting that a permeability defect contributed to the high carbapenem MICs of FIPP-1.

Transformants showing resistance or reduced susceptibility to all β-lactams (Table (Table1)1) were obtained by electroporation of Escherichia coli XL-1 blue with a plasmid preparation (11) from FIPP-1. Transformants yielded a positive PCR result for the blaKPC, blaTEM, and blaOXA-9 genes, suggesting that the three β-lactamase determinants were carried on the same plasmid, as previously observed (4).

PCR mapping and sequencing with primers KPC_istB_fw (5′-GCTACCGCTTGAAGGACAAG-3′) and KPC_tnpA_Rev (5′-GTCAATGCCAAGACCCATCC-3′), targeting blaKPC-flanking sequences (4, 7, 8), showed that in FIPP-1, blaKPC-3 was carried in a Tn4401a genetic context identical to that found in ST 258 blaKPC-3-positive isolates from Israel but different from the Tn4401b context of blaKPC-positive isolates from other countries (4, 7, 8).

Epidemiological analysis did not reveal any recent travel to settings of KPC endemicity. The only potential link with an area of endemicity was the presence of a training physician visiting from Israel, who had cared for the patient. The identity of ST and genetic context of blaKPC-3 with those of KPC-producing isolates from Israel (7, 12) support a similar origin. Pharyngeal and rectal swabs voluntarily provided by the trainee 2 months after the case report were negative for K. pneumoniae. However, this finding could not rule out colonization by a KPC-producing strain at the time of the patient's care.

Carbapenem resistance in the Enterobacteriaceae is still very uncommon in Italy ( To the best of our knowledge, FIPP-1 is the first KPC-producing K. pneumoniae strain detected in Italy, a finding of major concern due to the high spreading propensity that KPC-positive K. pneumoniae of ST 258 has shown in other settings, with dramatic consequences for the epidemiology of antibiotic resistance. This report also underscores the potential role of the mobility of training health care personnel in the international dissemination of similar multidrug-resistant strains.


This work was partially supported by funding from the European Commission under the 7th Framework Programme (TROCAR contract HEALTH-F3-2008-223031) and by a grant from the Italian Ministry for University and Research (PRIN2007).


[down-pointing small open triangle]Published ahead of print on 16 September 2009.


1. Baraniak, A., R. Izdebski, M. Herda, J. Fiett, W. Hryniewicz, M. Gniadkowski, I. Kern-Zdanowicz, K. Filczak, and U. Lopaciuk. 20 July 2009. The emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob. Agents Chemother. doi:.10.1128/AAC.00436-09 [PMC free article] [PubMed] [Cross Ref]
2. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Diancourt, L., V. Passet, J. Verhoef, P. A. Grimont, and S. Brisse. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182. [PMC free article] [PubMed]
4. Gootz, T. D., M. K. Lescoe, F. Dib-Hajj, B. A. Dougherty, W. He, P. Della-Latta, and R. C. Huard. 2009. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob. Agents Chemother. 53:1998-2004. [PMC free article] [PubMed]
5. Hawser, S. P., S. K. Bouchillon, D. J. Hoban, M. Hackel, J. L. Johnson, and R. E. Badal. 2009. Klebsiella pneumoniae isolates possessing KPC β-lactamase in Israel, Puerto Rico, Colombia and Greece. Int. J. Antimicrob. Agents 34:384-385. [PubMed]
6. Kaczmarek, F. M., F. Dib-Hajj, W. Shang, and T. D. Gootz. 2006. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob. Agents Chemother. 50:3396-3406. [PMC free article] [PubMed]
7. Kitchel, B., J. K. Rasheed, J. B. Patel, A. Srinivasan, S. Navon-Venezia, Y. Carmeli, A. Brolund, and C. G. Giske. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53:3365-3370. [PMC free article] [PubMed]
8. Naas, T., G. Cuzon, M. V. Villegas, M. F. Lartigue, J. P. Quinn, and P. Nordmann. 2008. Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob. Agents Chemother. 52:1257-1263. [PMC free article] [PubMed]
9. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236. [PubMed]
10. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458. [PMC free article] [PubMed]
11. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Samuelsen, O., U. Naseer, S. Tofteland, D. H. Skutlaberg, A. Onken, R. Hjetland, A. Sundsfjord, and C. G. Giske. 2009. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J. Antimicrob. Chemother. 63:654-658. [PubMed]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)